Assertio Holdings, Inc. (ASRT)
23.37
-0.07
(-0.30%)
USD |
NASDAQ |
May 21, 16:00
23.37
0.00 (0.00%)
After-Hours: 19:59
Assertio Holdings Research and Development Expense (TTM) : 1.706M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | 51.70M |
| Corcept Therapeutics, Inc. | 260.44M |
| Merck & Co., Inc. | 21.57B |
| Lipocine, Inc. | 10.23M |
| Theravance Biopharma, Inc. | 30.20M |